Start-up | Ex: Biotechnology
Strategic leader with extensive experience building and managing high-performing process engineering teams to develop autonomous laboratory solutions.
Start-up
Built and scaled a cross-disciplinary process engineering team which architects closed-loop experimentation ecosystems by integrating Agentic AI, to accelerate workflows optimization and implementation in diverse scientific spaces. Led the strategy for and enabled the development of a natural language interface for automated liquid handling, which supports dynamic, method-free operation and significant increases in operational flexibility. Oversees diverse technical domains and supports the bridge between laboratory science and engineering to establish systems for end-to-end process optimization. Fostered a high-performance culture resulting in rapid career advancement for direct reports and recognition in field-wide conventions.
Biotechnology
Led the onboarding of diverse automation technologies and qualified analytical assays on these platforms. Ensured compliance with GMP and 21 CFR Part 11 regulations for instrument purchases and protocols even when guidance for automation was lacking. Managed operational budgets and established vendor relationships to optimize resource availability. Founded and chaired an automation working group and collaborated with IT and Laboratory Information Management (LIMS) vendor to implement electronic data capture and LIMS capabilities. Directly managed junior scientists and co-ops while leading technical trainings for platform programming and data analysis software. Advocated for group culture as a member of the DEI Committee, executing cross-functional events to support team engagement.
Biotechnology
Managed cross-functional collaborations to design and execute experiments in the life sciences pre-clinical research space. Developed, qualified, and quality-controlled diverse processes including flow cytometry, CFU, cell culture, and qPCR assays. Supported automation of high-throughput sample preparation for Next Generation Sequencing on Illumina platforms. Formed and led an assay development working group.
Fund for Public Health in NYC
Generated hypotheses and conducted high-throughput next-generation sequencing of COVID-19 samples with Illumina and Nanopore technologies. Analyzed sequencing datasets, authored reports, and implemented SOPs. Validated a multiplexed qPCR and two MALDI-TOF assays to detect Mycobacteria in clinical specimens. Developed training materials and provided hands-on training for technicians on new assays and lab processes. Maintained compliance with CLEP, CLIA, and HIPAA regulations.
Hourly rate
$300